R&D Industry Finds Biosimilar Interchangeability Statement By EU Regulators ‘Concerning’

 
• By Francesca Bruce
  
Interchangeable
Biosimilars and reference products are interchangeable, say the EMA and HMA • Source: Shutterstock
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Europe

More from Geography